Literature DB >> 18382641

Where have All the Antibiotics Gone?

Julian Davies1.   

Abstract

The discovery of antibiotics some 60 years ago was anticipated to herald the end of infectious diseases. However, microbial evolution and genetic jugglery have dispelled this notion; the constant increase in the appearance of resistant strains has not been matched by the introduction of new therapeutic agents. On the contrary, the dire need for novel antibiotics has coincided with a reduction in antibiotic discovery programs in the pharmaceutical industry. As a result, the treatment of microbial diseases has reached a point where many infections are essentially untreatable by the antimicrobial agents currently available. At the present time, numerous initiatives are being undertaken by physicians and by governments in an attempt to redress this situation. In addition, alternative approaches to antibiotics for the treatment of infectious diseases are being explored intensively.

Entities:  

Keywords:  Alternative therapies; Antibiotic resistance; Mechanisms

Year:  2006        PMID: 18382641      PMCID: PMC2095086          DOI: 10.1155/2006/707296

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  12 in total

Review 1.  Why is big Pharma getting out of antibacterial drug discovery?

Authors:  Steven J Projan
Journal:  Curr Opin Microbiol       Date:  2003-10       Impact factor: 7.934

2.  Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life.

Authors:  Matthew R Parsek; Clay Fuqua
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

Review 3.  Lessons from natural molecules.

Authors:  Jon Clardy; Christopher Walsh
Journal:  Nature       Date:  2004-12-16       Impact factor: 49.962

4.  Antibiotics at the crossroads.

Authors:  Carl Nathan
Journal:  Nature       Date:  2004-10-21       Impact factor: 49.962

5.  Sampling the antibiotic resistome.

Authors:  Vanessa M D'Costa; Katherine M McGrann; Donald W Hughes; Gerard D Wright
Journal:  Science       Date:  2006-01-20       Impact factor: 47.728

Review 6.  Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.

Authors:  George H Talbot; John Bradley; John E Edwards; David Gilbert; Michael Scheld; John G Bartlett
Journal:  Clin Infect Dis       Date:  2005-01-25       Impact factor: 9.079

Review 7.  Molecular evolution of multiply-antibiotic-resistant staphylococci.

Authors:  R A Skurray; N Firth
Journal:  Ciba Found Symp       Date:  1997

Review 8.  Integrons: natural tools for bacterial genome evolution.

Authors:  D A Rowe-Magnus; D Mazel
Journal:  Curr Opin Microbiol       Date:  2001-10       Impact factor: 7.934

Review 9.  Resistance integrons and super-integrons.

Authors:  A C Fluit; F-J Schmitz
Journal:  Clin Microbiol Infect       Date:  2004-04       Impact factor: 8.067

Review 10.  Antibiotics in animal feed and their role in resistance development.

Authors:  Henrik C Wegener
Journal:  Curr Opin Microbiol       Date:  2003-10       Impact factor: 7.934

View more
  45 in total

1.  All models are wrong, but some are useful: Averting the 'microbial apocalypse'.

Authors:  Siouxsie Wiles
Journal:  Virulence       Date:  2015       Impact factor: 5.882

2.  Highly brominated antimicrobial metabolites from a marine Pseudoalteromonas sp.

Authors:  Domonkos Fehér; Russell Barlow; Jesse McAtee; Thomas K Hemscheidt
Journal:  J Nat Prod       Date:  2010-10-25       Impact factor: 4.050

3.  Beyond antibiotics?

Authors:  L E Nicolle
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

4.  The relationship among antibiotic consumption, socioeconomic factors and climatic conditions.

Authors:  Fawziah Marra; Sunny Mak; Mei Chong; David M Patrick
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

Review 5.  Enhancing the utility of existing antibiotics by targeting bacterial behaviour?

Authors:  Geraint B Rogers; Mary P Carroll; Kenneth D Bruce
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 6.  Genetic Approaches to Facilitate Antibacterial Drug Development.

Authors:  Dirk Schnappinger
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-13       Impact factor: 6.915

Review 7.  Does the Recent Growth of Aquaculture Create Antibiotic Resistance Threats Different from those Associated with Land Animal Production in Agriculture?

Authors:  Hansa Y Done; Arjun K Venkatesan; Rolf U Halden
Journal:  AAPS J       Date:  2015-02-21       Impact factor: 4.009

8.  A Dual-Mechanism Antibiotic Kills Gram-Negative Bacteria and Avoids Drug Resistance.

Authors:  James K Martin; Joseph P Sheehan; Benjamin P Bratton; Gabriel M Moore; André Mateus; Sophia Hsin-Jung Li; Hahn Kim; Joshua D Rabinowitz; Athanasios Typas; Mikhail M Savitski; Maxwell Z Wilson; Zemer Gitai
Journal:  Cell       Date:  2020-06-03       Impact factor: 41.582

Review 9.  New agents for the treatment of drug-resistant Mycobacterium tuberculosis.

Authors:  Daniel T Hoagland; Jiuyu Liu; Robin B Lee; Richard E Lee
Journal:  Adv Drug Deliv Rev       Date:  2016-05-02       Impact factor: 15.470

Review 10.  The calcium-dependent lipopeptide antibiotics: structure, mechanism, & medicinal chemistry.

Authors:  Thomas M Wood; Nathaniel I Martin
Journal:  Medchemcomm       Date:  2019-03-21       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.